Blog

By Andrew Kantor

Women have been dealing with menopause for a couple of hundred thousand years, and yet there’s still a bit of a stigma talking about it, the effects it can have on a woman’s body, and ways to help alleviate some of those negative issues.

Worse, as this article in the Atlantic explains, many gynecologists will try to solve everything with estrogen (or, if they’re British, oestrogen). Since the 1960s it’s been the go-to magic bullet for women in and after menopause.

Reality, though, is more complex — and we’ve learned a lot since the ’60s. Still, though, the lack of a “frank approach to sexuality” for both people born female and those who have transitioned there has kept many from realizing the benefits of other hormones. (Ironically, trans women often get better care when it comes to hormones.)

The point

By Andrew Kantor

Florida Representative Shane Abbott paid a visit to Revelation Pharma family member Everwell Specialty Pharmacy in Pensacola, Fla., where he had a dynamic conversation on pharmacy compounding, regulatory reform, and the hurdles confronting patients and pharmacists alike. Notably, Representative Abbott stands out as one of only two pharmacists serving in the Florida legislature; he also owns a pharmacy on the Florida panhandle.

A staunch advocate for healthcare affordability and transparency, Representative Abbott shared invaluable insights on key legislative endeavors aimed at tackling pressing issues

By Andrew Kantor

On April 10, members of the Alliance for Pharmacy Compounding, California compounders, and other stakeholders gathered at the California state capitol in Sacramento to spend the day meeting with 21 different offices of the state legislature to address the challenges compounders are facing in the state. Also there was Revelation Pharma’s government affairs associate, Katie Johnston.

On April 10, compounders split into three groups, each of which would meet with seven state legislators of various parties, backgrounds, and influence (and/or their staff). Those meetings ran from 9:30 a.m. through 4:30 p.m., and each focused on introducing the the legislator to the world of compounding and to raise attention to issues compounders have with the California Board of Pharmacy.

By Andrew Kantor

The whole issue of compounding GLP-1 agonists like semaglutide is fraught with land mines and misinformation — disinformation, even.

It's good, then, that the Game Changers Pharmacotherapy Podcast had a couple of guests who know what they're talking about to clear some of the air: Tenille Davis, PharmD, RPh (chief advocacy officer for the Alliance for Pharmacy Compounding) and Scott Brunner, CAE (CEO of APC). The host — Geoff Wall, PharmD — has the chops, too; he's a professor of pharmacy practice at Drake University.

It covers everything you need to know about compounding GLP-1s, including access, cost, and how shortages come into play. Even better, you might be able to get a half-hour of CPE credit, too!

Check out "Compounded GLP1s" on the Game Changers podcast — click